MILANA, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.613
EU - Europa 172
AS - Asia 58
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 1.847
Nazione #
US - Stati Uniti d'America 1.611
IE - Irlanda 65
IT - Italia 40
GB - Regno Unito 24
CN - Cina 21
KR - Corea 15
DE - Germania 13
SG - Singapore 10
CZ - Repubblica Ceca 6
BE - Belgio 5
UA - Ucraina 5
SE - Svezia 4
TM - Turkmenistan 4
CH - Svizzera 3
FI - Finlandia 3
RU - Federazione Russa 3
CA - Canada 2
IN - India 2
JP - Giappone 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
FR - Francia 1
MY - Malesia 1
TW - Taiwan 1
Totale 1.847
Città #
Wilmington 410
Houston 332
Chandler 171
Woodbridge 121
Fairfield 93
Ashburn 85
Dublin 56
Medford 49
New York 36
Seattle 33
Cambridge 29
Ann Arbor 24
Rome 23
Lawrence 22
San Diego 17
Beijing 16
Seoul 14
Washington 12
Menlo Park 11
Creede 8
London 7
Palo Alto 7
Brussels 5
Miami 5
Singapore 5
Dearborn 4
Bloomfield 3
Brno 3
Colorado Springs 3
Hounslow 3
Moscow 3
Bagnoregio 2
Engelhard 2
Esslingen am Neckar 2
Fremont 2
Hangzhou 2
Jacksonville 2
Kilburn 2
Kunming 2
Lahore 2
Norwalk 2
Nuremberg 2
Olomouc 2
Santa Clara 2
Toronto 2
Zurich 2
Adliswil 1
Boardman 1
Canberra 1
Chieti 1
Chiswick 1
Falls Church 1
Gunzenhausen 1
Helsinki 1
Invorio 1
Kuala Lumpur 1
Lappeenranta 1
Leawood 1
Magenta 1
Monmouth Junction 1
Mumbai 1
Munich 1
Petriolo 1
Radeberg 1
Redwood City 1
Rochester 1
San Mateo 1
Southwark 1
São Paulo 1
Taipei 1
Tower Hamlets 1
Wandsworth 1
Zhengzhou 1
Totale 1.667
Nome #
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 398
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 173
Domino liver transplantation: Where are we now? 139
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 134
The evolving scenario of HBV infection and disease: A never-ending story 132
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 128
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 113
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 75
Natremia and liver transplantation: The right amount of salt for a good recipe 64
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 64
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 56
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 52
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 47
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 40
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 40
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 39
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development 38
COVID-19 in normal, diseased and transplanted liver 34
Moving forward in the treatment of cholangiocarcinoma 34
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 31
Chronic rejection after liver transplantation: Opening the Pandora's box 30
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 21
Secondary bile acids and the biliary epithelia: The good and the bad 18
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 15
Use of Intravascular Ultrasound to Improve Diagnosis and Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction in Patients in the Long-term Follow-up 12
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 10
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 9
Sequence of events leading to primary biliary cholangitis 5
Totale 1.951
Categoria #
all - tutte 8.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020288 6 7 5 6 8 10 8 5 44 75 58 56
2020/2021616 64 60 51 57 57 97 104 73 13 23 12 5
2021/2022305 11 38 12 8 7 33 27 17 37 27 16 72
2022/2023369 34 46 19 36 45 66 33 29 28 11 14 8
2023/2024200 17 4 25 6 38 81 2 2 6 3 2 14
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 1.951